Meet with us at ASGCT 2026
Scroll
Dylan Serillon (PharmD, PhD), our Global Director of Drug Design, is giving an oral presentation on our latest in vivo results on AI-guided rAAV capsid engineering on May 13 at 10:15 AM. Our team is also available throughout the conference to discuss how ALFRED applies across therapeutic contexts.